NFL Players Lace Up for Muscular Dystrophy Association’s Mission in 2025 ‘My Cause My Cleats’ Campaign for Giving Tuesday

This year marks Hines’s fifth consecutive season dedicating his cleats to MDA’s cause. He continues to champion the mission through his public service announcement for MDA and fundraising initiatives, ...
Fierce Biotech

Novartis CEO paid top dollar for Avidity to become a 'leader in neuromuscular diseases'

Novartis may have signed off on the second-largest pharma acquisition of 2025 so far, but as the company’s CEO sees it—it’s never about the price tag. | Novartis may have signed off on the second ...

Renowned Neuromuscular Expert Will Head New NYU Langone ALS Center

A neuromuscular medicine expert and leader in the field of amyotrophic lateral sclerosis (ALS), Jinsy A. Andrews, MD, joins NYU Langone Health's Department of Neurology to lead its ALS Center, which ...

Epirium Bio Presented Positive Phase 1 Safety, Pharmacokinetics and Pharmacodynamics Data for MF-300, Supporting its Role in Muscle Health, as a Late-Breaker at the ...

Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, presented Phase 1 data for its lead candidate, MF-300, at the ...
TipRanks on MSN

NewcelX Appoints Renowned Neurologist to Strengthen Scientific Advisory Board

NewcelX ( ($NCEL) ) has shared an announcement. On November 17, 2025, NewcelX Ltd. announced the appointment of Prof. Jeremy Shefner, MD, PhD, to ...
TMCnet

NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute

In his role on the SAB of NewcelX, Prof. Shefner will provide strategic guidance on the Company's programs in ALS, including ...

Biogen Gets CHMP Backing for Higher-Dose Spinraza

Biogen on Monday said the positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use covers the high-dose regimen of Spinraza for the treatment of 5q SMA, ...

High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

Positive CHMP opinion is based on data from the DEVOTE study which evaluated the high dose regimen of nusinersen in treatment-naive participants ...

🌱 Patch AM: Dallas families struggle to find care for neuromuscular diseases

The article 🌱 Patch AM: Dallas families struggle to find care for neuromuscular diseases appeared first on Dallas Patch. Hi ...
WCJB TV20

University of Florida lab helps patients better understand neuromuscular diseases

This week’s Tech Tuesday spotlights the Wang Lab at the University of Florida, which is focusing on neuromuscular disease ...
IEEE

Early Identification of Hepatic Disorders Using Machine Learning

Abstract: The liver is a crucial organ that supports essential metabolic processes and aids in detoxifying the body. In recent years, Hepatic disorders has drastically increased due to number of ...
The Lancet

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19 ...